Dextran sulfate sodium-induced acute colonic inflammation in angiotensin II type 1a receptor deficient mice

Inflammation Research

Volumn 57, Issue 2, 2008, Pages 84-91

  Katada, K ^a,b   Yoshida, N ^a   Suzuki, T ^a   Okuda, T ^a   Mizushima, K ^a   Takagi, T ^a   Ichikawa, H ^a   Naito, Y ^a   Cepinskas, G ^b   Yoshikawa, T ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Angiotensin II; AT1a receptor; Experimental colitis; Inflammation; TNF

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN II; DEXTRAN SULFATE; DRINKING WATER; MESSENGER RNA; MYELOPEROXIDASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION; WILD TYPE;

ANGIOTENSIN II; ANIMALS; BODY WEIGHT; COLITIS; COLON; DEXTRAN SULFATE; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEROXIDASE; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39749136117     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-007-7098-y     Document Type: Article

References (50)

1. Goodfriend Tl, Eliott ME, Catt KJ. Angiotensin receptors and their antagonists. N Engl J Med 1996; 334: 1649-54.
2. Yang LZ, Bataller R, Dulyx J, Coffman TM, Gines P, Rippe RA et al. Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice. J Hepatol 2005; 43: 317-23.
3. Chang E, Perlman AJ. Angiotensinogen mRNA Regulation by cell cycle and growth factors. J Biol Chem 1988; 263: 5480-4.
4. Maisch B. Ventricular remodeling. Cardiology 1996; 87: S1:2-10.
5. Lopez Farre A, Casado S. Heart failure, redox alterations, and endothelial dysfunction. Hypertension 2001; 38: 1400-5.
6. Moriyama T, Fujibayashi M, Fujiwara Y, Kaneko T, Xia C, Imai E et al. Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells. J Am Soc Nephrol 1995; 6: 95-101.
7. Ruiz-Ortega M, Ruperez M, Lorenzo O, Esteban V, Blanco J, Mezzano S et al. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl 2002; 82: 12-22.
8. Touyz RM, Schiffrin EL. Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 1999; 34: 976-82.
9. Inokuchi Y, Morohashi T, Kawana I, Nagashima Y, Kihara M, Umemura S. Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice. Gut 2005; 54: 349-56.
10. Wengrower D, Zannineli G, Pappo O, Latella G, Sestieri M, Villanova A et al. Prevention of fibrosis in experimental colitis by captopril: the role of tgf-beta1. Inflamm Bowel Dis 2004; 10: 536-45.
11. Jahovic N, Ercan F, Gedik N, Yuksel M, Sener G, Alican I. The effect of angiotensin-converting enzyme inhibitors on experimental colitis in rats. Regul Pept 2005; 130: 67-74.
12. Sugaya T, Nishimatsu S, Tanimoto K, Takimoto E, Yamagishi T, Imamura K et al. Angiotensin II type 1a receptor deficient mice with hypotension and hyperreninemia. J Biol Chem 1995; 270: 18719-22.
13. Oliverio MI, Madsen K, Best CF, Ito M, Maeda N, Smithies O et al. Renal growth and development in mice lacking AT1A receptors for angiotensin II. Am J Physiol 1998; 274: F43-50.
14. Hisada Y, Sugaya T, Yamanouchi M, Uchida H, Fujimura H, Sakurai H et al. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 1999; 103: 627-35.
15. Satoh M, Kashihara N, Yamasaki Y, Maruyama K, Okamoto K, Maeshima Y et al. Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor deficient mice. J Am Soc Nephrol 2001; 12: 317-25.
16. Daugherty A, Rateri DL, Lu H, Inagami T, Cassis LA. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1a receptor. Circulation 2004; 110: 3849-57.
17. Li Y, Kishimoto I, Saito Y, Harada M, Kuwahara K, Izumi T et al. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart. Circulation 2002; 106: 1722-8.
18. Imai N, Hashimoto T, Kihara M, Yoshida S, Kawana I, Yazawa T et al. Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis. Lab Invest 2007; 87:189-98.
19. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702.
20. Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE, Buchler MW. Characterisation of acute murine dextran sodium sulfate colitis: cytokine profile and dose dependency. Digestion 2000; 62: 240-8.
21. Jaszewski R, Tolia V, Ehrinpreis MN, Bodzin JH, Peleman RR, Korlipara R et al. Increased colonic mucosal angiotensin I and II concentrations in Crohn's colitis. Gastroenterology 1990; 98: 1543-8.
22. Naito Y, Takagi T, Ishikawa T, Handa O, Matsumoto N, Yagi N et al. The inducible nitric oxide synthase inhibitor ONO-1714 blunts dextran sulfate sodium colitis in mice. Eur J Pharmacol 2001; 412: 91-9.
23. Naito Y, Takagi T, Handa O, Ishikawa T, Nakagawa S, Yamaguchi T et al. Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice. J Gastroenterol Hepatol 2003; 18: 560-9.
24. Naito Y, Takagi T, Uchiyama K, Kuroda M, Kokura S, Ichikawa H et al. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6 deficient mice. Int J. Mol Med 2004; 14: 191-6.
25. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69: 238-49.
26. Ohkawa H, Ohnishi N, Yagi K. Assay for lipid peroxides for animal tissues by thiobarbituric acid reaction. Anal Biochem 1986; 95: 351-8.
27. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
28. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986; 252: G567-74.
29. Spencer AU, Yang H, Haxhija EQ, Wildhaber BE, Greenson JK, Teitelbaum DH. Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition. Dig Dis Sci 2007; 52:1060-70.
30. Matsuda T, Suzuki J, Furuya K, Masutani M, Kawakami Y. Serum angiotensin I-converting enzyme is reduced in Crohn's disease and ulcerative colitis irrespective of genotype. Am J Gastroenterol 2001; 96: 2705-10.
31. Camoglio L, te Velde AA, de Boer A, ten Kate FJ, Kopf M, van Deventer SJ. Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice. Eur J Immunol 2000; 30: 1486-95.
32. Ishioka T, Kuwabara N, Oohashi Y, Wakabayashi K. Induction of colorectal tumors in rats by sulfated polysaccharides. Crit Rev Toxicol. 1987; 17: 215-44.
33. Peluso I, Pallone F, Monteleone G. Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication. World J Gastroenterol 2006; 21: 5606-10.
34. Grisham MB, Volkmer C, Tso P, Yamada T. Metabolism on trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology 1991; 101: 540-7.
35. Keshavarzian A, Morgan G, Sedghi S, Gordon JH, Doria M. Role of reactive oxygen metabolites in experimental colitis. Gut 1990; 31: 786-90.
36. Hemanowicz A, Gibson PR, Jewell DP. The role of phagocytes in inflammatory bowel disease. Clin Sci 1985; 69: 177-84.
37. Wallace JL, McKnight W, Asfaha S, Liu DY. Reduction of acute and reactivated colitis in rats by an inhibitor of neutrophil activation. Am J Physiol 1998; 274: G802-8.
38. Yoshikawa T, Yamaguchi T, Yoshida N, Yamamoto H, Kitazumi S, Takahashi S et al. Effect of TNB-induced colitis in rats. Digestion 1997; 58: 464-8.
39. Hirasawa K, Sato Y, Hosoda Y, Yamamoto T, Hanai H. Immunohistochemical localization of angiotensin II receptor and local renninangiotensin system in human colonic mucosa. J Histochem Cytochem 2002; 50: 275-82.
40. Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 1986; 78: 31-9.
41. Paul M, Wagner J, Dzau VJ. Gene expression of the rennin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. J Clin Invest 1993; 91: 2058-64.
42. Bekay RE, Alvarez M, Monteseirin J, Alba G, Chacon P, Vega A et al. Oxidative stress is a critical mediator of the angiotensin II signal in a human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-κB. Blood 2003; 102: 662-71.
43. Chen R, Iwai M, Wu L, Min LJ, Shiuchi T, Sugaya T et al. Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury. Hypertension 2003; 42: 542-7.
44. Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, Bohm M et al. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res 2004; 94: 534-41.
45. Kranzhofer R, Browatzki M, Schmidt J, Kubler W. Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocyte. Biochem Biophys Res Commun 1999; 257: 826-8.
46. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Amal JF, Michel JB. Angiotensin stimulates endothelial vascular cell adhision molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Bio 2000; 20:645-51.
47. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 2003; 24: 471-8.
48. Ushio-Fukai M, Alexander RW. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 2004; 264: 85-97.
49. Alvarez A, Cerda-Nicolas M, Naim Abu Nabah Y, Mata M, Issekutz AC, Panes J et al. Direct evidence of leukocyte adhesion in arterioles by angiotensin II. Blood 2004; 104: 402-8.
50. Takagi T, Yoshida N, Isozaki Y, Shimozawa M, Katada K, Manabe H et al. CV-11974, angiotensin II type I receptor antagonist, protects against ischemia-reperfusion injury of the small intestine in rats. Eur J Pharmacol 2006; 27: 283-90.